ASPIRA PATHLAB & DIAGNOSTICS LTD: JAY ARVIND BHANUSHALI ACQUIRES 0.002% STAKE IN OPEN MARKET

• Disclosure pursuant to Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. • Details pertains to the acquisition of 245 equity shares (0.002%) in Aspira Pathlab & Diagnostics Ltd. • Prior holding: 7,49,262 shares (7.28%). • Post acquisition holding: 7,49,507 shares (7.28%). • Acquisition was pursuant to open market purchase. • Date of acquisition: September 28, 2026. • Total equity share capital of the target company is Rs 10,29,30,000 divided into 1,02,93,000 equity shares of Rs 10 each. Impact: Neutral (Routine disclosure of shareholding change)

Aspira Pathlab & Diagnostics Ltd

Open attachment

← Back to feed